Cargando…

Outcome Improvement in RPA I or II Patients With 1 or 2 Brain Metastases by Combined Surgery and Radiotherapy

BACKGROUND: To evaluate the role of surgery and postoperative radiotherapy in the management of brain metastases (BM): a retrospective analysis for overall survival (OS), local and brain control (LC and BC) of a series of 329 patients with recursive partitioning analysis (RPA) I or II with 1 or 2 BM...

Descripción completa

Detalles Bibliográficos
Autores principales: Antoni, Delphine, Kehrli, Pierre, Clavier, Jean-Baptiste, Lahlou, Mohamed Amine, Lefebvre, Francois, Noel, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649917/
https://www.ncbi.nlm.nih.gov/pubmed/29147328
http://dx.doi.org/10.4021/wjon626w
_version_ 1783272633524027392
author Antoni, Delphine
Kehrli, Pierre
Clavier, Jean-Baptiste
Lahlou, Mohamed Amine
Lefebvre, Francois
Noel, Georges
author_facet Antoni, Delphine
Kehrli, Pierre
Clavier, Jean-Baptiste
Lahlou, Mohamed Amine
Lefebvre, Francois
Noel, Georges
author_sort Antoni, Delphine
collection PubMed
description BACKGROUND: To evaluate the role of surgery and postoperative radiotherapy in the management of brain metastases (BM): a retrospective analysis for overall survival (OS), local and brain control (LC and BC) of a series of 329 patients with recursive partitioning analysis (RPA) I or II with 1 or 2 BM in a single institution. METHODS: Patients were treated either with combined surgical resection and whole brain radiation therapy (WBRT) in 104 cases (31.6%) or with WBRT alone in 225 cases (68.4%). Ninety-five patients (91.4%) who underwent surgery and WBRT and 147 (65.3%) who underwent WBRT alone benefited from a radiation boost to the metastatic site. RESULTS: The median OS was higher for patients RPA I compared to RPA II: 21.3 and 5.9 months (P < 0.0001), as well as for the surgical group compared to the radiation group: 20.2 vs 5.3 months (P < 0.0001), respectively. After the multivariate analysis, the improved OS was significantly associated with control of primary tumor (P = 0.0002) after surgical resection and with type of primary tumor (P = 0.002), absence of extracranial metastases (ECM) (P = 0.006), and high Karnofsky performance status (90 - 100 vs 70 - 80) (P = 0.003) after radiotherapy alone. The 12-, 24- and 36-months LC rates were 91.1%, 91.1% and 83.9%, respectively, after surgical resection and 81.2%, 63.1% and 57.3%, respectively, after radiotherapy alone (P = 0.005). In a univariate analysis, improved LC for the surgical group was also associated with the absence of ECM (P = 0.01) and for the radiation group, with a radiation boost (P = 0.01). The BC rates at 12, 24 and 36 months were 73.2%, 66.9% and 56%, respectively, in the surgical group and 75.7%, 49.6% and 42.4%, respectively, in the radiation group (P = 0.2). In our univariate analysis, improved BC after surgical resection was associated with control of primary tumor (P = 0.02). For patients in the radiation group, gender (P = 0.03) and a radiation boost (P = 0.0003) were significant prognostic factors in a univariate analysis. In our multivariate analysis, only the radiation boost was significant (P = 0.001). CONCLUSIONS: Surgical resection followed by WBRT leads to a better outcome compared to WBRT alone for RPA I or II patients with 1 or 2 BM.
format Online
Article
Text
id pubmed-5649917
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-56499172017-11-16 Outcome Improvement in RPA I or II Patients With 1 or 2 Brain Metastases by Combined Surgery and Radiotherapy Antoni, Delphine Kehrli, Pierre Clavier, Jean-Baptiste Lahlou, Mohamed Amine Lefebvre, Francois Noel, Georges World J Oncol Original Article BACKGROUND: To evaluate the role of surgery and postoperative radiotherapy in the management of brain metastases (BM): a retrospective analysis for overall survival (OS), local and brain control (LC and BC) of a series of 329 patients with recursive partitioning analysis (RPA) I or II with 1 or 2 BM in a single institution. METHODS: Patients were treated either with combined surgical resection and whole brain radiation therapy (WBRT) in 104 cases (31.6%) or with WBRT alone in 225 cases (68.4%). Ninety-five patients (91.4%) who underwent surgery and WBRT and 147 (65.3%) who underwent WBRT alone benefited from a radiation boost to the metastatic site. RESULTS: The median OS was higher for patients RPA I compared to RPA II: 21.3 and 5.9 months (P < 0.0001), as well as for the surgical group compared to the radiation group: 20.2 vs 5.3 months (P < 0.0001), respectively. After the multivariate analysis, the improved OS was significantly associated with control of primary tumor (P = 0.0002) after surgical resection and with type of primary tumor (P = 0.002), absence of extracranial metastases (ECM) (P = 0.006), and high Karnofsky performance status (90 - 100 vs 70 - 80) (P = 0.003) after radiotherapy alone. The 12-, 24- and 36-months LC rates were 91.1%, 91.1% and 83.9%, respectively, after surgical resection and 81.2%, 63.1% and 57.3%, respectively, after radiotherapy alone (P = 0.005). In a univariate analysis, improved LC for the surgical group was also associated with the absence of ECM (P = 0.01) and for the radiation group, with a radiation boost (P = 0.01). The BC rates at 12, 24 and 36 months were 73.2%, 66.9% and 56%, respectively, in the surgical group and 75.7%, 49.6% and 42.4%, respectively, in the radiation group (P = 0.2). In our univariate analysis, improved BC after surgical resection was associated with control of primary tumor (P = 0.02). For patients in the radiation group, gender (P = 0.03) and a radiation boost (P = 0.0003) were significant prognostic factors in a univariate analysis. In our multivariate analysis, only the radiation boost was significant (P = 0.001). CONCLUSIONS: Surgical resection followed by WBRT leads to a better outcome compared to WBRT alone for RPA I or II patients with 1 or 2 BM. Elmer Press 2013-02 2013-03-06 /pmc/articles/PMC5649917/ /pubmed/29147328 http://dx.doi.org/10.4021/wjon626w Text en Copyright 2013, Antoni et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Antoni, Delphine
Kehrli, Pierre
Clavier, Jean-Baptiste
Lahlou, Mohamed Amine
Lefebvre, Francois
Noel, Georges
Outcome Improvement in RPA I or II Patients With 1 or 2 Brain Metastases by Combined Surgery and Radiotherapy
title Outcome Improvement in RPA I or II Patients With 1 or 2 Brain Metastases by Combined Surgery and Radiotherapy
title_full Outcome Improvement in RPA I or II Patients With 1 or 2 Brain Metastases by Combined Surgery and Radiotherapy
title_fullStr Outcome Improvement in RPA I or II Patients With 1 or 2 Brain Metastases by Combined Surgery and Radiotherapy
title_full_unstemmed Outcome Improvement in RPA I or II Patients With 1 or 2 Brain Metastases by Combined Surgery and Radiotherapy
title_short Outcome Improvement in RPA I or II Patients With 1 or 2 Brain Metastases by Combined Surgery and Radiotherapy
title_sort outcome improvement in rpa i or ii patients with 1 or 2 brain metastases by combined surgery and radiotherapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649917/
https://www.ncbi.nlm.nih.gov/pubmed/29147328
http://dx.doi.org/10.4021/wjon626w
work_keys_str_mv AT antonidelphine outcomeimprovementinrpaioriipatientswith1or2brainmetastasesbycombinedsurgeryandradiotherapy
AT kehrlipierre outcomeimprovementinrpaioriipatientswith1or2brainmetastasesbycombinedsurgeryandradiotherapy
AT clavierjeanbaptiste outcomeimprovementinrpaioriipatientswith1or2brainmetastasesbycombinedsurgeryandradiotherapy
AT lahloumohamedamine outcomeimprovementinrpaioriipatientswith1or2brainmetastasesbycombinedsurgeryandradiotherapy
AT lefebvrefrancois outcomeimprovementinrpaioriipatientswith1or2brainmetastasesbycombinedsurgeryandradiotherapy
AT noelgeorges outcomeimprovementinrpaioriipatientswith1or2brainmetastasesbycombinedsurgeryandradiotherapy